Publication Name	World Journal of Gastroenterology
Manuscript ID	8438
Country	South Korea

Received	2013-12-28 14:16
Peer-Review Started	2013-12-28 18:37
To Make the First Decision	2014-02-14 12:58
Return for Revision	2014-02-20 13:16
Revised	2014-03-10 11:04
Second Decision	2014-06-17 09:14
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-17 09:45
Articles in Press	2014-06-17 10:08
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-06-24 14:55
Typeset the Manuscript	2014-09-15 19:34
Publish the Manuscript Online	2014-10-07 17:32

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics?
Manuscript Source	Invited Manuscript
All Author List	Jong-Min Park, Na Young Han, Young-Min Han, Mi Kyung Chung, Hoo Keun Lee, Kwang Hyun Ko, Eun-Hee Kim and Ki Baik Hahm
Funding Agency and Grant Number	Funding Agency Grant Number Ministry of Education and Science Technology 2010-0002052 Korea and JSPS Asian CORE Program, Japan
Corresponding Author	Ki Baik Hahm, MD, PhD, Professor, CHA Cancer Prevention Research Center, CHA University, 605 Yeoksam 1-dong, Gangnam-gu, Seoul 135-081, South Korea. hahmkb@cha.ac.kr
Key Words	Inflammatory bowel disease; Biomarker; Proteomics; Tailored medicine; Colitic cancer
Core Tip	Our recent achievements in discovering biomarkers to predict cancer risk are introduced. Ultimately, models based on combinations of genotype and gene expression data referenced with clinical, biochemical, and serological data may permit the development of tools for individualized risk stratification and efficient treatment selection, as well as complete rescue from complications, including colitis-associated cancer, in the near future.
Publish Date	2014-10-07 17:32
Citation	Park JM, Han NY, Han YM, Chung MK, Lee HK, Ko KH, Kim EH, Hahm KB. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics? World J Gastroenterol 2014; 20(37): 13466-12476
URL	http://www.wjgnet.com/1007-9327/full/v20/i37/13466.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i37.13466

Full Article (PDF)	WJG-20-13466.pdf
Full Article (Word)	WJG-20-13466.doc
Manuscript File	8438-Review.docx
Answering Reviewers	8438-Answering reviewers.pdf
Copyright License Agreement	8438-Copyright assignment.PDF
Non-Native Speakers of English Editing Certificate	8438-Language certificate.pdf
Peer-review Report	8438-Peer reviews.pdf
Scientific Misconduct Check	8438-CrossCheck.jpg
Scientific Editor Work List	8438-Scientific editor work list.pdf